Skip to content

Entravision Communications, Inc. EVC Fair Value Of Put And Call Options

Fair Value Of Put And Call Options at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$19.3M+117%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$236.63M-456%
Capital City Bank Group logo
Capital City Bank GroupCCBG
$5.32M0.0%
US Physical Therapy logo
US Physical TherapyUSPH
$363K+190%
DJT
Trump Media & Technology GroupDJT
$13.92M
KKR & Co. logo
KKR & Co.KKR
$1.15B+71.1%

Other financials

Income statement

See full
Revenue$197.0M+114%
Gross profit$95.0M+62.8%
Operating income$20.7M+139%
Net income$12.4M+126%
EPS (diluted)$0.13+125%

Balance sheet

See full
Cash & equivalents$68.2M-7.4%
Total debt$210.1M-10.7%
Total equity$65.0M-32.1%
Total assets$436.4M+0.1%

Cash flow

See full
Operating cash flow$21.8M+243%
CapEx$3.6M+37.6%
Free cash flow$18.1M+201%

Valuation

See full
Market cap$1.05B+412%
Enterprise value$1.19B+225%
P/S1.9×+1.4×

Profitability

See full
Gross margin54.3%-15.9pp
Operating margin-1.8%-0.9pp
Net margin-3.4%-1.6pp
FCF margin4.7%-11.6pp

Returns & leverage

See full
Return on equity-23.5%-10.3pp
Debt / equity3.2×+0.8×
Current ratio1.4×-1.5×

Where this comes from

Reported directly by Entravision Communications, Inc. in its filing.

Tagged under the XBRL concept evc:FairValueOfPutAndCallOptions.

The official record: Entravision Communications, Inc.’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Entravision Communications, Inc.'s fair value of put and call options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Entravision Communications, Inc.'s fair value of put and call options?
Entravision Communications, Inc. (EVC) reported fair value of put and call options of $10.9M in Q4 2023.
What does fair value of put and call options mean?
This metric tracks the valuation of derivative instruments, specifically put and call options, held by the company or granted to minority interest holders. These instruments often arise from joint venture agreements or equity-based partnerships and can significantly impact the company's future equity structure. It provides insight into potential future cash obligations or equity dilution risks associated with complex ownership arrangements.